CIK 1599882
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 53.66% | 47 |
| Health Care Equipment & Supplies | 17.69% | 15 |
| Insurance | 6.17% | 5 |
| Health Care Providers & Services | 6.15% | 6 |
| Distributors | 4.53% | 3 |
| Food & Staples Retailing | 2.98% | 1 |
| Technology Hardware & Equipment | 2.93% | 2 |
| Life Sciences Tools & Services | 2.02% | 3 |
| Software | 1.85% | 1 |
| Software & IT Services | 1.55% | 2 |
| Unclassified | 0.47% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BSX | BOSTON SCIENTIFIC CORP | Health Care | 4.84% |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | Health Care | 4.59% |
| 3 | LLY | ELI LILLY & Co | Health Care | 3.83% |
| 4 | INSM | INSMED Inc | Health Care | 3.22% |
| 5 | CVS | CVS HEALTH Corp | Consumer Staples | 2.98% |
| 6 | GILD | GILEAD SCIENCES, INC. | Health Care | 2.88% |
| 7 | TMO | THERMO FISHER SCIENTIFIC INC. | Information Technology | 2.51% |
| 8 | BIIB | BIOGEN INC. | Health Care | 2.47% |
| 9 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Health Care | 2.40% |
| 10 | ALHC | Alignment Healthcare, Inc. | Financials | 2.29% |
85/86 names classified · sector 99.5% of weight · industry 99.5% · mkt cap 99.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 99.5% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 59.7% of book weight (40/86 names) · unclassified 40.3%: INSM, ALHC, JAZZ, GH, MDGL, PRCT, RPRX, AXSM, NTRA, ADPT +36 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BSXBOSTON SCIENTIFIC CORP | 625,000 | $39M | 4.8% | ADD 45% |
| 2 | REGNREGENERON PHARMACEUTICALS | 48,100 | $37M | 4.6% | TRIM −22% |
| 3 | LLYELI LILLY & CO | 33,715 | $31M | 3.8% | TRIM −20% |
| 4 | INSMINSMED INC | 159,760 | $26M | 3.2% | ADD 41% |
| 5 | CVSCVS HEALTH CORP | 336,500 | $24M | 3.0% | HOLD |
| 6 | GILDGILEAD SCIENCES INC | 167,750 | $23M | 2.9% | ADD 33% |
| 7 | TMOTHERMO FISHER SCIENTIFIC INC | 41,340 | $20M | 2.5% | ADD 23% |
| 8 | BIIBBIOGEN INC | 109,100 | $20M | 2.5% | ADD 18% |
| 9 | VRTXVERTEX PHARMACEUTICALS INC | 43,485 | $19M | 2.4% | ADD 27% |
| 10 | ALHCALIGNMENT HEALTHCARE INC | 1,053,450 | $19M | 2.3% | ADD 4% |
| 11 | ISRGINTUITIVE SURGICAL INC | 36,846 | $17M | 2.1% | TRIM −23% |
| 12 | CORCENCORA INC | 52,375 | $16M | 2.0% | TRIM −17% |
| 13 | SYKSTRYKER CORPORATION | 47,800 | $16M | 1.9% | NEW |
| 14 | ABBVABBVIE INC | 71,575 | $16M | 1.9% | TRIM −35% |
| 15 | VEEVVEEVA SYS INC | 85,300 | $15M | 1.8% | NEW |
| 16 | MCKMCKESSON CORP | 16,850 | $15M | 1.8% | TRIM −34% |
| 17 | JAZZJAZZ PHARMACEUTICALS PLC | 75,890 | $14M | 1.8% | ADD 3% |
| 18 | GHGUARDANT HEALTH INC | 145,000 | $13M | 1.7% | ADD 81% |
| 19 | NBIXNEUROCRINE BIOSCIENCES INC | 100,841 | $13M | 1.6% | TRIM −20% |
| 20 | EWEDWARDS LIFESCIENCES CORP | 163,000 | $13M | 1.6% | TRIM −16% |
| 21 | MDGLMADRIGAL PHARMACEUTICALS INC | 24,050 | $13M | 1.6% | ADD 23% |
| 22 | UNHUNITEDHEALTH GROUP INC | 45,500 | $12M | 1.5% | TRIM −17% |
| 23 | PRCTPROCEPT BIOROBOTICS CORP | 475,000 | $12M | 1.5% | TRIM −22% |
| 24 | BMRNBIOMARIN PHARMACEUTICAL INC | 207,000 | $12M | 1.4% | TRIM −4% |
| 25 | ABTABBOTT LABS | 112,000 | $11M | 1.4% | NEW |
| 26 | ALNYALNYLAM PHARMACEUTICALS INC | 34,465 | $11M | 1.4% | TRIM −25% |
| 27 | RPRXROYALTY PHARMA PLC | 233,000 | $11M | 1.4% | ADD 13% |
| 28 | AXSMAXSOME THERAPEUTICS INC. | 63,800 | $11M | 1.3% | TRIM −44% |
| 29 | NTRANATERA INC | 51,600 | $10M | 1.3% | ADD 27% |
| 30 | THCTenet Healthcare Corp. | 54,000 | $10M | 1.3% | TRIM −29% |
| 31 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 720,000 | $10M | 1.2% | ADD 19% |
| 32 | LIVNLIVANOVA PLC | 155,000 | $10M | 1.2% | TRIM −18% |
| 33 | ELVELEVANCE HEALTH INC FORMERLY | 32,300 | $9M | 1.2% | ADD 115% |
| 34 | ARWRARROWHEAD PHARMACEUTICALS IN | 144,500 | $9M | 1.1% | HOLD |
| 35 | GKOSGLAUKOS CORP | 84,000 | $9M | 1.1% | TRIM −60% |
| 36 | IQVIQVIA HLDGS INC | 53,000 | $9M | 1.1% | ADD 100% |
| 37 | SNDXSYNDAX PHARMACEUTICALS INC | 379,250 | $9M | 1.1% | TRIM −22% |
| 38 | MIRMMIRUM PHARMACEUTICALS INC | 92,605 | $9M | 1.1% | TRIM −13% |
| 39 | IDYAIDEAYA BIOSCIENCES INC | 255,500 | $9M | 1.1% | ADD 2% |
| 40 | PNTGPENNANT GROUP INC | 275,399 | $8M | 1.0% | TRIM −23% |
| 41 | NUVLNUVALENT INC | 81,200 | $8M | 1.0% | TRIM −50% |
| 42 | WAYWAYSTAR HLDG CORP | 342,566 | $8M | 1.0% | NEW |
| 43 | AVRANTERIS TECHNOLOGIES GLOBAL | 1,438,625 | $8M | 1.0% | ADD 16% |
| 44 | MDTMEDTRONIC PLC | 90,000 | $8M | 1.0% | TRIM −70% |
| 45 | OSCROSCAR HEALTH INC | 660,000 | $8M | 0.9% | ADD 154% |
| 46 | IOVAIOVANCE BIOTHERAPEUTICS INC | 2,055,327 | $7M | 0.9% | ADD 29% |
| 47 | MLYSMINERALYS THERAPEUTICS INC | 263,071 | $7M | 0.9% | ADD 85% |
| 48 | IONSIONIS PHARMACEUTICALS INC | 92,900 | $7M | 0.9% | TRIM −41% |
| 49 | DNTHDIANTHUS THERAPEUTICS INC | 81,627 | $7M | 0.8% | TRIM −17% |
| 50 | BBIOBRIDGEBIO PHARMA INC | 90,600 | $7M | 0.8% | ADD 11% |
| 51 | APGEAPOGEE THERAPEUTICS INC | 75,000 | $6M | 0.8% | NEW |
| 52 | GPCRSTRUCTURE THERAPEUTICS INC | 128,100 | $6M | 0.8% | TRIM −13% |
| 53 | CAHCARDINAL HEALTH INC | 27,000 | $6M | 0.7% | NEW |
| 54 | EHCENCOMPASS HEALTH CORP | 56,263 | $5M | 0.7% | TRIM −62% |
| 55 | AMGNAMGEN INC | 15,200 | $5M | 0.7% | TRIM −58% |
| 56 | VKTXVIKING THERAPEUTICS INC | 160,000 | $5M | 0.6% | ADD 93% |
| 57 | NRIXNURIX THERAPEUTICS INC | 313,500 | $5M | 0.6% | TRIM −42% |
| 58 | ALKSALKERMES PLC | 133,250 | $5M | 0.6% | HOLD |
| 59 | CRLCHARLES RIV LABS INTL INC | 26,000 | $4M | 0.6% | ADD 18% |
| 60 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 239,500 | $4M | 0.6% | TRIM −34% |
| 61 | KRYSKRYSTAL BIOTECH INC | 16,675 | $4M | 0.5% | TRIM −33% |
| 62 | DOCSDOXIMITY INC | 183,808 | $4M | 0.5% | TRIM −51% |
| 63 | NKTRNEKTAR THERAPEUTICS | 59,000 | $4M | 0.5% | NEW |
| 64 | DNLIDENALI THERAPEUTICS INC | 199,000 | $4M | 0.5% | ADD 99% |
| 65 | STVNSTEVANATO GROUP S P A | 274,676 | $4M | 0.5% | ADD 87% |
| 66 | RLAYRELAY THERAPEUTICS INC | 360,000 | $4M | 0.4% | TRIM −22% |
| 67 | COOCOOPER COS INC | 50,000 | $4M | 0.4% | TRIM −85% |
| 68 | SIONSIONNA THERAPEUTICS INC | 87,500 | $4M | 0.4% | NEW |
| 69 | ASNDASCENDIS PHARMA A/S | 15,000 | $3M | 0.4% | HOLD |
| 70 | DHRDANAHER CORP DEL | 18,052 | $3M | 0.4% | TRIM −82% |
| 71 | PODDINSULET CORP | 14,000 | $3M | 0.4% | TRIM −77% |
| 72 | AAGILENT TECHNOLOGIES INC | 25,000 | $3M | 0.4% | ADD 25% |
| 73 | STOKSTOKE THERAPEUTICS INC | 83,000 | $3M | 0.3% | TRIM −62% |
| 74 | ESPRESPERION THERAPEUTICS INC NE | 985,000 | $3M | 0.3% | NEW |
| 75 | IMCRIMMUNOCORE HLDGS PLC | 85,724 | $3M | 0.3% | TRIM −44% |
| 76 | OCULOCULAR THERAPEUTIX INC | 305,000 | $3M | 0.3% | ADD 15% |
| 77 | STESTERIS PLC | 11,500 | $3M | 0.3% | ADD 92% |
| 78 | VCELVERICEL CORP | 70,000 | $2M | 0.3% | TRIM −40% |
| 79 | KURAKURA ONCOLOGY INC | 271,500 | $2M | 0.3% | TRIM −69% |
| 80 | CITHE CIGNA GROUP | 8,000 | $2M | 0.3% | TRIM −79% |
| 81 | BTSGBRIGHTSPRING HEALTH SVCS INC | 50,000 | $2M | 0.3% | TRIM −75% |
| 82 | XENEXENON PHARMACEUTICALS INC | 28,000 | $2M | 0.2% | TRIM −80% |
| 83 | ALGNALIGN TECHNOLOGY INC | 7,500 | $1M | 0.2% | TRIM −92% |
| 84 | NVCRNOVOCURE LTD | 70,000 | $763,000 | 0.1% | NEW |
| 85 | ATECALPHATEC HLDGS INC | 70,000 | $761,600 | 0.1% | ADD 250% |
| 86 | CMPXCOMPASS THERAPEUTICS INC | 115,113 | $608,948 | 0.1% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| BSXBOSTON SCIENTIFIC CORP | 444K | 300K | 296K | 438K | 431K | 625K | $39M |
| REGNREGENERON PHARMACEUTICALS | 43K | 32K | 28K | 36K | 61K | 48K | $37M |
| LLYELI LILLY & CO | 45K | 42K | 58K | 53K | 42K | 34K | $31M |
| INSMINSMED INC | 62K | 186K | 175K | 132K | 114K | 160K | $26M |
| CVSCVS HEALTH CORP | 268K | 236K | 295K | 277K | 336K | 337K | $24M |
| GILDGILEAD SCIENCES INC | 256K | 234K | 168K | 80K | 126K | 168K | $23M |
| TMOTHERMO FISHER SCIENTIFIC INC | 16K | 13K | 11K | 30K | 34K | 41K | $20M |
| BIIBBIOGEN INC | 124K | 50K | 12K | 55K | 92K | 109K | $20M |
| VRTXVERTEX PHARMACEUTICALS INC | 50K | 67K | 61K | 47K | 34K | 43K | $19M |
| ALHCALIGNMENT HEALTHCARE INC | 1.8M | 1.3M | 1.3M | 1.5M | 1.0M | 1.1M | $19M |
| ISRGINTUITIVE SURGICAL INC | 64K | 52K | 44K | 49K | 48K | 37K | $17M |
| CORCENCORA INC | 54K | 32K | 49K | 62K | 63K | 52K | $16M |
| SYKSTRYKER CORPORATION | 23K | — | 12K | — | — | 48K | $16M |
| ABBVABBVIE INC | 124K | 89K | 69K | 130K | 111K | 72K | $16M |
| VEEVVEEVA SYS INC | — | — | — | — | — | 85K | $15M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
